Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report

Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report

Advanced hepatocellular carcinoma (HCC) is a highly lethal disease, mainly due to the late stage at diagnosis and its rapid progression. Although patients with advanced HCC can choose targeted therapy or chemotherapy, overall, the treatment response rate is extremely low and the average survival tim...

Full description

Bibliographic Details
Main Authors: Chenxi Liu, Jie Shao, Yanbing Dong, Qiuping Xu, Zhengyun Zou, Fangjun Chen, Jing Yan, Juan Liu, Shuangshuang Li, Baorui Liu, Jie Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
neoantigen reactive T cells
immunotherapy
tomotherapy
benefit
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.685126/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.685126/full

Similar Items